HbA1c rose to 58 mmol/mol a | HbA1c increased 10 mmol/mol b | Change of T2DM drugs c | Combination of all definitions | |||||
---|---|---|---|---|---|---|---|---|
HR | 95%CI | HR | 95%CI | HR | 95%CI | HR | 95%CI | |
Crude model | ||||||||
Using GnRH, n (%) | ||||||||
No PCa | 1.00 | ref. | 1.00 | ref. | 1.00 | ref. | 1.00 | ref. |
No | 0.94 | (0.88–1.00) | 1.02 | (0.96–1.08) | 0.94 | (0.84–1.04) | 0.96 | (0.92–1.01) |
Yes | 1.20 | (1.08–1.33) | 1.38 | (1.26–1.51) | 1.13 | (0.95–1.34) | 1.21 | (1.11–1.31) |
PCa diagnosis | ||||||||
No | 1.00 | Ref. | 1.00 | ref. | 1.00 | ref. | 1.00 | ref. |
Yes | 0.99 | (0.94–1.05) | 1.10 | (1.04–1.15) | 0.98 | (0.89–1.07) | 1.02 | (0.97–1.06) |
PCa risk category | ||||||||
No PCa | 1.00 | ref. | 1.00 | ref. | 1.00 | ref. | 1.00 | ref. |
Low risk | 0.91 | (0.81–1.02) | 0.99 | (0.89–1.10) | 1.15 | (0.98–1.36) | 0.97 | (0.88–1.06) |
Intermediate risk | 0.97 | (0.89–1.06) | 1.00 | (0.92–1.09) | 0.94 | (0.81–1.10) | 1.00 | (0.93–1.07) |
High risk | 0.95 | (0.85–1.05) | 1.10 | (1.01–1.21) | 0.85 | (0.71–1.01) | 0.98 | (0.90–1.06) |
Regional metastasises | 1.25 | (1.04–1.52) | 1.44 | (1.21–1.70) | 1.06 | (0.76–1.49) | 1.25 | (1.07–1.46) |
Distance metastasises | 1.31 | (1.11–1.53) | 1.55 | (1.35–1.78) | 0.81 | (0.58–1.13) | 1.21 | (1.06–1.38) |
Missing data | 1.04 | (0.77–1.40) | 1.06 | (0.82–1.38) | 1.34 | (0.87–2.06) | 0.95 | (0.75–1.20) |
Adjusted model d | ||||||||
GnRH, n (%) | ||||||||
No PCa | 1.00 | ref. | 1.00 | ref. | 1.00 | ref. | 1.00 | ref. |
No | 0.97 | (0.91–1.03) | 1.06 | (1.00–1.12) | 0.94 | (0.84–1.04) | 0.98 | (0.93–1.03) |
Yes | 1.23 | (1.11–1.36) | 1.41 | (1.28–1.54) | 1.20 | (1.01–1.42) | 1.24 | (1.13–1.34) |
PCa diagnosis | ||||||||
No | 1.00 | ref. | 1.00 | ref. | 1.00 | ref. | 1.00 | ref. |
Yes | 1.03 | (0.97–1.08) | 1.14 | (1.08–1.19) | 0.99 | (0.90–1.09) | 1.04 | (0.99–1.08) |
PCa risk category | ||||||||
No PCa | 1.00 | ref. | 1.00 | ref. | 1.00 | ref. | 1.00 | ref. |
Low risk | 0.95 | (0.84–1.06) | 1.04 | (0.94–1.15) | 1.12 | (0.95–1.32) | 0.99 | (0.90–1.08) |
Intermediate risk | 1.01 | (0.92–1.10) | 1.05 | (0.97–1.14) | 0.95 | (0.81–1.10) | 1.02 | (0.95–1.10) |
High risk | 0.97 | (0.87–1.07) | 1.13 | (1.03–1.24) | 0.90 | (0.75–1.07) | 1.00 | (0.92–1.08) |
Regional metastases | 1.29 | (1.07–1.56) | 1.47 | (1.24–1.74) | 1.14 | (0.82–1.59) | 1.28 | (1.10–1.50) |
Distance metastases | 1.36 | (1.16–1.60) | 1.59 | (1.38–1.82) | 0.88 | (0.63–1.22) | 1.23 | (1.09–1.40) |
Missing data | 0.96 | (0.71–1.29) | 1.01 | (0.78–1.31) | 1.22 | (0.80–1.88) | 0.92 | (0.73–1.16) |